DeLuca Teresa 4

What Happened
Teresa DeLuca, a director of Surgery Partners, acquired 11,670 shares as an award on June 5, 2026. The grant is recorded at $13.71 per share for a total reported value of $159,996. This was an equity award (acquisition), not a sale.

Key Details

• Transaction date: 2026-06-05; Transaction type: Award/Grant (code A)
• Price per share: $13.71; Total reported value: $159,996
• Vesting: Shares will vest on June 5, 2027 (footnote F1)
• Shares owned after transaction: Not specified in the Form 4 filing
• Filing date: 2026-06-09 — appears timely (filed within the SEC’s 2-business-day window for a June 5 trade)
• No 10b5-1 plan, tax withholding, or other special conditions were disclosed in the filing

Context
This was a restricted stock award, meaning the shares are subject to vesting (here, one year) and may be forfeitable until vested. Awards are acquisitions (a constructive insider purchase) and are commonly used for compensation and retention; they do not by themselves indicate the director bought shares on the open market or immediate intent to sell.